Yamanaka on the new iPSC trials for wet AMD in Japan. Part 1.

Head on over to Paul Knoepfler’s blog and check out hisYamanaka Interview on Clinical Use of Pluripotent Stem Cells.

I don’t know. I’ll be posting more about this tomorrow, but… suffice it to say right now that I wish I could get more excited about this new study with iPSC’s. I think they’re rushing wayyyyyy too fast to use these techniques on a human subject, especially when you look at all the pre-clinical problems and questions. And there were A LOT.

 

And I think we could have all lived without this quote:

 

At the same time, the ethical issues that hESC possess mean that as iPSC technology improves, hESC will be less needed. Still, iPSC is a new technology, and its safety and efficacy still needs to be confirmed.

 

Um, hello, EARTH TO DR. YAMANAKA. There ARE no “ethical issues.” Seriously, you don’t know about Robert Lanza’s blastomere technique, which doesn’t destroy the embryo?. And yep, no kidding that iPSC’s safety needs to be confirmed, much less their efficacy. Maybe we shouldn’t be blithely testing these cells on human beings right now.

 

That’s enough of a rant for today, but there will be more tomorrow!

Cathy Danielson
Follow me!

Cathy Danielson

In 2011, my life was shattered when I was diagnosed with a mysterious, incurable disease that always ends in blindness. The only hope on the horizon was a drug that broke all barriers in early testing. This drug, which replaces damaged cells in the eye, comes from the new class of stem cell based treatments that could cure the incurable, providing hope for patients with cancer, heart failure, ALS, cerebral palsy, and many more fatal and disabling diseases.

I survived the disease, and I now have the only remission on record. But a remission is not a cure. The stem cell drug I need for a real cure is now rapidly moving towards approval in the rest of the world, but in the USA, it—and all other cellular therapies-- are still stuck behind prejudice, ignorance, and lack of funding. Hundreds of millions of desperate patients with incurable diseases need these drugs.

That’s why I’ve gone on to fight for greater public education on stem cell drugs, knowing that our laws must be changed so that all of us can get access to the best treatments instead of our health and our lives being held hostage by special interests.

I’m now a patient advocate whose work on stem cells and patients’ rights has been published in outlets such as the Oregonian. I am a manager at popular science and financial blog www.stemcellinvestor.com and a frequent speaker at many venues across the spectrum, including churches, scientific conferences, and atheist groups, and everything in between. I’m also an advocate for Right to Try laws that would allow access to experimental medication for terminal patients at the state level. Read the entire story in my upcoming book, And the Blind Shall See: A Skeptic Patient Surprised by Faith, Science, Family, and Miracle Cures.
Cathy Danielson
Follow me!

Leave a Reply

Your email address will not be published. Required fields are marked *